Cost Plus Drugs is an online pharmacy created to simplify how prescription drugs are priced and sold in the United States. Its model is built on a straightforward idea: list the actual cost of a medication, add a fixed 15 percent markup, add a small pharmacy fee, and show the final price directly to the consumer. This approach removes the hidden negotiations, middlemen, and complex pricing structures that many Americans find confusing.
The traditional prescription drug supply chain involves wholesalers, pharmacy benefit managers, and insurers, each taking a cut. These layers often result in wide price differences between pharmacies, even for the same drug. Cost Plus Drugs aims to eliminate most of that complexity by acting as both a wholesaler and a pharmacy, which reduces the number of parties involved and lowers the final cost.
This transparency is appealing to people looking for ways to reduce out of pocket healthcare spending and to understand their medical expenses with the same clarity they apply to budgeting or investing.
Who is Mark Cuban?
Mark Cuban is an entrepreneur known for building and selling technology companies, investing in startups, and becoming a public figure through his ownership of the Dallas Mavericks. His business career has always emphasized efficiency, innovation, and direct problem solving, which shows up in the design of Cost Plus Drugs.
He launched the company because he believed that prescription drug prices in the United States were too high, often without explanation or clear justification. By creating a business that openly lists its costs and profit margins, he wanted to challenge an industry known for opaque pricing. The mission is to make essential medications more affordable, especially for people without insurance or for those with high deductible plans who must pay out of pocket until they meet their deductible.
Cuban has emphasized that the company is designed to pressure the broader industry into more competitive and transparent behavior.
How Much Do Americans Spend on Medicine Annually?
Prescription drug spending in the United States is among the highest in the world. Americans spend hundreds of billions of dollars each year on medications, and retail prescription drug spending reached $467 billion in 2024 (per CMS National Health Expenditure data), up 7.9%, with weight-loss GLP-1 drugs the top driver of growth. Rising prices for common medications, an aging population, and increased use of specialty drugs all contribute to this figure.
For households focused on financial independence, these costs can weigh heavily on long term planning. Medical expenses are a major budget category, and high drug prices can make it harder to save, invest, and maintain a stable emergency fund. This is one reason why transparent pricing and lower cost alternatives resonate with so many consumers.
Tools that help you understand your money, like budgeting apps and personal finance books, teach that clarity and simplicity matter. Cost Plus Drugs aligns with that mindset by showing people exactly what they are paying for and why. It encourages consumers to learn more about their healthcare spending the same way they learn about investing or managing monthly cash flow.
2026: the push into brand-name drugs
Cost Plus Drugs started with generics, but 2026 is the year it moved upmarket. In January, the company announced a manufacturing alliance with Alchem Laboratories to develop essential medicines and collaborate on supplying 86 essential medicines and medical countermeasures, a step toward making its own supply chain instead of just reselling through it. Then in April, Bristol Myers Squibb and Pfizer agreed to sell Eliquis, one of the most widely prescribed blood thinners in the country, through Cost Plus Drugs at $345 for a 30-day supply starting April 27. That is a brand-name drug, not a generic, and it signals where the company is headed: the same transparent formula applied to the expensive drugs that drive most household drug spending.
The formula itself has not changed. As of 2026 the price is still the company’s cost plus a 15 percent markup, a $5 pharmacy fee, and $5.25 for shipping, and the company ships to all 50 states. The bet is that transparency scales: if the model works for a $10 generic, it can work for a $345 brand-name prescription too.
Cost Plus Drugs has quickly become part of the broader conversation about how Americans can take more control over their financial lives. By shining a light on the cost of essential medications, it gives people another tool to make informed and responsible financial choices.
You must be logged in to post a comment.